Archive
145 evidence-based reports across medicine, nutrition, mental well-being, chronic conditions, and healthcare technology.
Showing 12 of 145 stories · page 6 of 13
The 2026 ACC/AHA dyslipidemia guideline says every adult should be tested once for Lp(a), adds ApoB and 30-year risk, and brings back specific LDL targets. Here is what the changes mean for you.
The 2026 MAHA agenda pushes supplement oversight and GRAS reform, yet peptides like BPC-157 are sold as 'research only' outside drug rules. Here is the regulatory contradiction and the risk to buyers.
The 2026 Medicare sleep-apnea changes added prior authorization in six states, a 12-month sleep-study validity window, and a strict 4-hour compliance rule. Here is what beneficiaries must do to keep coverage.
The 2026 CDC RSV guidance says adults 75+ and at-risk adults 50–74 should get one dose, and it is not an annual shot. Here is the timing and the group that qualifies this season.
The FDA has now cleared more than 1,000 AI-enabled medical devices, with radiology leading the way. Here is what clearance actually means, where the evidence is solid, and what to watch for.
The FDA approved bemotrizinol in June 2026, the first new sunscreen active ingredient in more than two decades. Here is what it does, how it differs from current filters, and when it will reach shelves.
The 2026 ACC/AHA dyslipidemia guideline replaces the 2018 recommendations with earlier screening, new PREVENT risk equations, universal Lp(a) testing, and lower LDL-C targets for many patients.
The AHA and ACC issued the first clinical guideline for cardiovascular-kidney-metabolic syndrome in June 2026. Here is what the four-stage system means for your care.
Congress and the FTC took aim at pharmacy benefit managers in 2026. Here is what changed, when it takes effect, and how it could lower your prescription costs.
The 2026 Dysautonomia International conference launched a new ME/CFS biobank, and recent studies identified potential blood-based biomarkers for post-exertional malaise. Here is what is ready now and what remains experimental.
:max_bytes(150000):strip_icc()/VWM-ADHDinWomenSignsandSymptoms_final-efbb964a72474f06a5f9b1eae2eec62c.png)
Perimenopause and ADHD share strikingly similar symptoms. A 2025 population study found women with ADHD report nearly double the rate of severe perimenopausal symptoms.
The EPA issued new interim guidance on PFAS destruction and disposal in April 2026, and NRDC warned that PFAS microplastics are a global contaminant found in human blood, placenta, lung tissue, and semen. Here is what to do now.
